| 0 |
SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS |
1 |
0.2500 |
| 1 |
URINE AMPHETAMINE NEGATIVE |
2 |
0.0741 |
| 2 |
THERAPEUTIC AGENT URINE NEGATIVE |
1 |
0.0400 |
| 3 |
POOR SCHOOL ATTENDANCE |
1 |
0.0400 |
| 4 |
SPECIALIST CONSULTATION |
1 |
0.0357 |
| 5 |
UNHEALTHY DIET |
1 |
0.0200 |
| 6 |
DRUG TITRATION |
2 |
0.0128 |
| 7 |
ALCOHOL TEST FALSE POSITIVE |
1 |
0.0106 |
| 8 |
COMPULSIVE LIP BITING |
1 |
0.0096 |
| 9 |
TOE WALKING |
1 |
0.0085 |
| 10 |
INJECTION SITE MOVEMENT IMPAIRMENT |
1 |
0.0078 |
| 11 |
PENILE DISCOMFORT |
1 |
0.0078 |
| 12 |
CHANGE IN SUSTAINED ATTENTION |
2 |
0.0066 |
| 13 |
FIBROMUSCULAR DYSPLASIA |
1 |
0.0061 |
| 14 |
VITAMIN B12 ABNORMAL |
1 |
0.0051 |
| 15 |
SEVERE CUTANEOUS ADVERSE REACTION |
1 |
0.0042 |
| 16 |
VAGUS NERVE DISORDER |
1 |
0.0040 |
| 17 |
ONYCHOPHAGIA |
1 |
0.0036 |
| 18 |
TONGUE MOVEMENT DISTURBANCE |
3 |
0.0035 |
| 19 |
GENITAL PARAESTHESIA |
1 |
0.0034 |
| 20 |
DERMATILLOMANIA |
2 |
0.0034 |
| 21 |
SPONTANEOUS PENILE ERECTION |
2 |
0.0032 |
| 22 |
STEREOTYPY |
3 |
0.0032 |
| 23 |
TIC |
17 |
0.0031 |
| 24 |
GRANDIOSITY |
1 |
0.0027 |
| 25 |
PATIENT ELOPEMENT |
1 |
0.0027 |
| 26 |
BLUNTED AFFECT |
2 |
0.0027 |
| 27 |
PHYSICAL EXAMINATION ABNORMAL |
1 |
0.0026 |
| 28 |
SUICIDE THREAT |
1 |
0.0026 |
| 29 |
MANUFACTURING MATERIALS ISSUE |
1 |
0.0025 |
| 30 |
VITAMIN D ABNORMAL |
1 |
0.0024 |
| 31 |
DRUG SCREEN NEGATIVE |
4 |
0.0023 |
| 32 |
PRODUCT DOSAGE FORM ISSUE |
1 |
0.0021 |
| 33 |
TONGUE ERUPTION |
1 |
0.0020 |
| 34 |
EXPULSION OF MEDICATION |
1 |
0.0019 |
| 35 |
AUTOSCOPY |
1 |
0.0019 |
| 36 |
THERAPEUTIC RESPONSE SHORTENED |
61 |
0.0018 |
| 37 |
REPETITIVE SPEECH |
1 |
0.0018 |
| 38 |
LACRIMAL DISORDER |
1 |
0.0017 |
| 39 |
NEGATIVE THOUGHTS |
5 |
0.0017 |
| 40 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
7 |
0.0017 |
| 41 |
NEUROPSYCHOLOGICAL SYMPTOMS |
1 |
0.0017 |
| 42 |
BACILLUS INFECTION |
1 |
0.0016 |
| 43 |
FEELINGS OF WORTHLESSNESS |
2 |
0.0015 |
| 44 |
ALLERGIC REACTION TO EXCIPIENT |
3 |
0.0015 |
| 45 |
PATIENT-DEVICE INCOMPATIBILITY |
1 |
0.0015 |
| 46 |
PAINFUL ERECTION |
1 |
0.0015 |
| 47 |
GRIMACING |
1 |
0.0013 |
| 48 |
CROUP INFECTIOUS |
1 |
0.0013 |
| 49 |
PARATHYROID DISORDER |
1 |
0.0012 |
| 50 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 51 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 52 |
LUNG OPERATION |
1 |
0.0012 |
| 53 |
DRUG DOSE TITRATION NOT PERFORMED |
2 |
0.0011 |
| 54 |
DISTURBANCE IN SEXUAL AROUSAL |
1 |
0.0011 |
| 55 |
DISORGANISED SPEECH |
2 |
0.0011 |
| 56 |
INITIAL INSOMNIA |
11 |
0.0011 |
| 57 |
TONGUE INJURY |
1 |
0.0011 |
| 58 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 59 |
LIBIDO INCREASED |
2 |
0.0010 |
| 60 |
GASTRIC PH DECREASED |
1 |
0.0010 |
| 61 |
SELF-INJURIOUS IDEATION |
4 |
0.0010 |
| 62 |
GASTRIC BYPASS |
2 |
0.0009 |
| 63 |
PHOBIA |
1 |
0.0009 |
| 64 |
CHEMICAL BURN |
1 |
0.0009 |
| 65 |
DISTRACTIBILITY |
1 |
0.0009 |
| 66 |
INTRUSIVE THOUGHTS |
1 |
0.0008 |
| 67 |
PSYCHOMOTOR HYPERACTIVITY |
14 |
0.0008 |
| 68 |
LEARNING DISORDER |
2 |
0.0008 |
| 69 |
SUFFOCATION FEELING |
2 |
0.0008 |
| 70 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 71 |
IMPULSIVE BEHAVIOUR |
3 |
0.0008 |
| 72 |
EMOTIONAL DISORDER |
22 |
0.0007 |
| 73 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 74 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 75 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 76 |
IMPETIGO |
1 |
0.0007 |
| 77 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 78 |
ANGER |
22 |
0.0006 |
| 79 |
DAYDREAMING |
1 |
0.0006 |
| 80 |
IRRITABILITY |
38 |
0.0006 |
| 81 |
EDUCATIONAL PROBLEM |
1 |
0.0006 |
| 82 |
FOOD AVERSION |
1 |
0.0006 |
| 83 |
CHOREA |
1 |
0.0006 |
| 84 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 85 |
TACHYPHRENIA |
2 |
0.0006 |
| 86 |
ALOPECIA AREATA |
1 |
0.0006 |
| 87 |
LOGORRHOEA |
2 |
0.0006 |
| 88 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 89 |
FEAR OF DISEASE |
1 |
0.0006 |
| 90 |
OBSESSIVE THOUGHTS |
1 |
0.0006 |
| 91 |
NASAL OEDEMA |
1 |
0.0006 |
| 92 |
MANIA |
9 |
0.0005 |
| 93 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 94 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 95 |
BLADDER SPASM |
1 |
0.0005 |
| 96 |
AFFECT LABILITY |
5 |
0.0005 |
| 97 |
DISTURBANCE IN ATTENTION |
28 |
0.0005 |
| 98 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
2 |
0.0005 |
| 99 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 100 |
TONGUE BITING |
1 |
0.0005 |
| 101 |
PSYCHOTIC SYMPTOM |
1 |
0.0005 |
| 102 |
SOCIAL PROBLEM |
2 |
0.0005 |
| 103 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 104 |
ERECTION INCREASED |
2 |
0.0005 |
| 105 |
SLEEP DEFICIT |
1 |
0.0005 |
| 106 |
FEELING JITTERY |
9 |
0.0005 |
| 107 |
HENOCH-SCHONLEIN PURPURA |
1 |
0.0005 |
| 108 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 109 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 110 |
FORMICATION |
3 |
0.0004 |
| 111 |
ABNORMAL BEHAVIOUR |
17 |
0.0004 |
| 112 |
HALLUCINATION, VISUAL |
9 |
0.0004 |
| 113 |
VOLVULUS |
1 |
0.0004 |
| 114 |
STARING |
1 |
0.0004 |
| 115 |
AGGRESSION |
20 |
0.0004 |
| 116 |
EYELID IRRITATION |
1 |
0.0004 |
| 117 |
PRODUCT PHYSICAL ISSUE |
8 |
0.0004 |
| 118 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 119 |
DRUG TITRATION ERROR |
1 |
0.0004 |
| 120 |
PANIC ATTACK |
14 |
0.0004 |
| 121 |
HALLUCINATION, AUDITORY |
6 |
0.0004 |
| 122 |
OBSESSIVE-COMPULSIVE DISORDER |
3 |
0.0004 |
| 123 |
LARYNGOSPASM |
1 |
0.0004 |
| 124 |
TRICHORRHEXIS |
1 |
0.0004 |
| 125 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 126 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 127 |
PRODUCT AVAILABILITY ISSUE |
8 |
0.0004 |
| 128 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 129 |
ENERGY INCREASED |
2 |
0.0003 |
| 130 |
BRADYKINESIA |
2 |
0.0003 |
| 131 |
TENSION |
2 |
0.0003 |
| 132 |
MOOD SWINGS |
10 |
0.0003 |
| 133 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 134 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 135 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 136 |
ANXIETY DISORDER |
1 |
0.0003 |
| 137 |
PRIAPISM |
1 |
0.0003 |
| 138 |
DROOLING |
2 |
0.0003 |
| 139 |
HYPERREFLEXIA |
1 |
0.0003 |
| 140 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 141 |
APPENDICECTOMY |
1 |
0.0003 |
| 142 |
TONGUE DISORDER |
2 |
0.0003 |
| 143 |
CRYING |
10 |
0.0003 |
| 144 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 145 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 146 |
ARTHROPOD BITE |
2 |
0.0003 |
| 147 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 148 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 149 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 150 |
DISSOCIATION |
2 |
0.0003 |
| 151 |
THYROID MASS |
1 |
0.0003 |
| 152 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 153 |
SUICIDAL IDEATION |
23 |
0.0003 |
| 154 |
ENURESIS |
1 |
0.0002 |
| 155 |
DYSKINESIA |
10 |
0.0002 |
| 156 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 157 |
SLEEP TERROR |
1 |
0.0002 |
| 158 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 159 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 160 |
AGITATION |
17 |
0.0002 |
| 161 |
PRODUCT COMMUNICATION ISSUE |
2 |
0.0002 |
| 162 |
HEART RATE INCREASED |
22 |
0.0002 |
| 163 |
ROSACEA |
1 |
0.0002 |
| 164 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 165 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 166 |
APATHY |
3 |
0.0002 |
| 167 |
THERAPY CHANGE |
2 |
0.0002 |
| 168 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 169 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 170 |
HYPOAESTHESIA ORAL |
3 |
0.0002 |
| 171 |
INTENTIONAL SELF-INJURY |
4 |
0.0002 |
| 172 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 173 |
SLUGGISHNESS |
2 |
0.0002 |
| 174 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 175 |
ADVERSE EVENT |
18 |
0.0002 |
| 176 |
TRISMUS |
1 |
0.0002 |
| 177 |
TONSILLITIS |
1 |
0.0002 |
| 178 |
BRAIN FOG |
3 |
0.0002 |
| 179 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 180 |
CATATONIA |
1 |
0.0002 |
| 181 |
DEPRESSED MOOD |
10 |
0.0002 |
| 182 |
IMPAIRED WORK ABILITY |
4 |
0.0002 |
| 183 |
BRUXISM |
1 |
0.0002 |
| 184 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 185 |
CHEILITIS |
1 |
0.0002 |
| 186 |
MOOD ALTERED |
5 |
0.0002 |
| 187 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 188 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 189 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 190 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 191 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 192 |
SKIN WARM |
1 |
0.0002 |
| 193 |
DECREASED INTEREST |
1 |
0.0002 |
| 194 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 195 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 196 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 197 |
BLEPHAROSPASM |
1 |
0.0002 |
| 198 |
SCREAMING |
1 |
0.0002 |
| 199 |
MYDRIASIS |
2 |
0.0002 |
| 200 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
11 |
0.0002 |
| 201 |
INCOHERENT |
1 |
0.0002 |
| 202 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 203 |
ANXIETY |
43 |
0.0002 |
| 204 |
APPETITE DISORDER |
1 |
0.0002 |
| 205 |
PRESCRIBED UNDERDOSE |
3 |
0.0002 |
| 206 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 207 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 208 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 209 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 210 |
INSOMNIA |
39 |
0.0001 |
| 211 |
DECREASED APPETITE |
34 |
0.0001 |
| 212 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 213 |
NIGHTMARE |
5 |
0.0001 |
| 214 |
HUNGER |
2 |
0.0001 |
| 215 |
TARDIVE DYSKINESIA |
4 |
0.0001 |
| 216 |
THERMAL BURN |
1 |
0.0001 |
| 217 |
RETCHING |
3 |
0.0001 |
| 218 |
INTENTIONAL DOSE OMISSION |
4 |
0.0001 |
| 219 |
HYPERSOMNIA |
4 |
0.0001 |
| 220 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 221 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 222 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 223 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 224 |
PSYCHOTIC DISORDER |
4 |
0.0001 |
| 225 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 226 |
FEELING DRUNK |
1 |
0.0001 |
| 227 |
SUNBURN |
1 |
0.0001 |
| 228 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
6 |
0.0001 |
| 229 |
HALLUCINATION |
10 |
0.0001 |
| 230 |
INSURANCE ISSUE |
2 |
0.0001 |
| 231 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 232 |
APHTHOUS ULCER |
1 |
0.0001 |
| 233 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 234 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 235 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 236 |
HICCUPS |
1 |
0.0001 |
| 237 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 238 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 239 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 240 |
THERAPEUTIC RESPONSE DECREASED |
7 |
0.0001 |
| 241 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 242 |
SKIN SWELLING |
1 |
0.0001 |
| 243 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 244 |
EAR INFECTION |
3 |
0.0001 |
| 245 |
THIRST |
2 |
0.0001 |
| 246 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 247 |
PALPITATIONS |
13 |
0.0001 |
| 248 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
| 249 |
RESTLESSNESS |
4 |
0.0001 |
| 250 |
THINKING ABNORMAL |
2 |
0.0001 |
| 251 |
ABDOMINAL PAIN UPPER |
22 |
0.0001 |
| 252 |
DYSTONIA |
2 |
0.0001 |
| 253 |
SKIN FISSURES |
2 |
0.0001 |
| 254 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 255 |
HEPATOMEGALY |
1 |
0.0001 |
| 256 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 257 |
TACHYCARDIA |
9 |
0.0001 |
| 258 |
BLADDER DISORDER |
1 |
0.0001 |
| 259 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 260 |
OVARIAN CYST |
1 |
0.0001 |
| 261 |
DRY THROAT |
1 |
0.0001 |
| 262 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 263 |
TREATMENT FAILURE |
8 |
0.0001 |
| 264 |
PETECHIAE |
1 |
0.0001 |
| 265 |
NERVOUSNESS |
5 |
0.0001 |
| 266 |
WITHDRAWAL SYNDROME |
4 |
0.0001 |
| 267 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 268 |
SCRATCH |
1 |
0.0001 |
| 269 |
MIGRAINE |
9 |
0.0001 |
| 270 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 271 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 272 |
DEPRESSION |
21 |
0.0001 |
| 273 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 274 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 275 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 276 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 277 |
FOOT DEFORMITY |
1 |
0.0001 |
| 278 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 279 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 280 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 281 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 282 |
NASAL CONGESTION |
5 |
0.0001 |
| 283 |
SOMNOLENCE |
17 |
0.0001 |
| 284 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 285 |
CHOLECYSTITIS |
1 |
0.0001 |
| 286 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 287 |
URTICARIA |
14 |
0.0001 |
| 288 |
NOCTURIA |
1 |
0.0001 |
| 289 |
LIVER INJURY |
2 |
0.0001 |
| 290 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 291 |
PHARYNGITIS |
1 |
0.0001 |
| 292 |
ILEUS |
1 |
0.0001 |
| 293 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 294 |
TREMOR |
13 |
0.0001 |
| 295 |
PRODUCT DOSE OMISSION ISSUE |
23 |
0.0001 |
| 296 |
THERAPY CESSATION |
4 |
0.0001 |
| 297 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 298 |
ECZEMA |
4 |
0.0001 |
| 299 |
SPEECH DISORDER |
4 |
0.0001 |
| 300 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 301 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 302 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 303 |
AKATHISIA |
1 |
0.0001 |
| 304 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 305 |
CONTUSION |
7 |
0.0001 |
| 306 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 307 |
FEELING COLD |
2 |
0.0001 |
| 308 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 309 |
HEADACHE |
44 |
0.0001 |
| 310 |
PARALYSIS |
1 |
0.0001 |
| 311 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 312 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 313 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 314 |
DRUG INEFFECTIVE |
91 |
0.0001 |
| 315 |
HYPOKINESIA |
1 |
0.0001 |
| 316 |
FLUSHING |
7 |
0.0001 |
| 317 |
FEELING ABNORMAL |
16 |
0.0001 |
| 318 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 319 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 320 |
TENDONITIS |
1 |
0.0001 |
| 321 |
DELUSION |
1 |
0.0001 |
| 322 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 323 |
OBESITY |
1 |
0.0001 |
| 324 |
SEIZURE |
7 |
0.0001 |
| 325 |
LIP SWELLING |
2 |
0.0001 |
| 326 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 327 |
PERICARDITIS |
1 |
0.0001 |
| 328 |
SCAR |
1 |
0.0001 |
| 329 |
PARANOIA |
1 |
0.0001 |
| 330 |
COLD SWEAT |
1 |
0.0001 |
| 331 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 332 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 333 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 334 |
TOOTHACHE |
1 |
0.0001 |
| 335 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 336 |
PHOTOPHOBIA |
1 |
0.0001 |
| 337 |
DYSARTHRIA |
2 |
0.0001 |
| 338 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 339 |
INCREASED APPETITE |
1 |
0.0001 |
| 340 |
LETHARGY |
3 |
0.0001 |
| 341 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 342 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 343 |
ERUCTATION |
1 |
0.0001 |
| 344 |
CHOKING |
1 |
0.0001 |
| 345 |
SURGERY |
3 |
0.0001 |
| 346 |
PARAESTHESIA |
8 |
0.0001 |
| 347 |
TASTE DISORDER |
1 |
0.0000 |
| 348 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 349 |
POLLAKIURIA |
2 |
0.0000 |
| 350 |
DERMATITIS |
1 |
0.0000 |
| 351 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 352 |
VOMITING |
22 |
0.0000 |
| 353 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 354 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 355 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 356 |
ANGIOEDEMA |
2 |
0.0000 |
| 357 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 358 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 359 |
CHROMATURIA |
1 |
0.0000 |
| 360 |
MEMORY IMPAIRMENT |
6 |
0.0000 |
| 361 |
SKIN IRRITATION |
2 |
0.0000 |
| 362 |
NAUSEA |
34 |
0.0000 |
| 363 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 364 |
NEURALGIA |
1 |
0.0000 |
| 365 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 366 |
EPISTAXIS |
3 |
0.0000 |
| 367 |
HYPOAESTHESIA |
6 |
0.0000 |
| 368 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 369 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 370 |
ACNE |
3 |
0.0000 |
| 371 |
HYPERHIDROSIS |
5 |
0.0000 |
| 372 |
SKIN ULCER |
1 |
0.0000 |
| 373 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 374 |
SEDATION |
1 |
0.0000 |
| 375 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 376 |
ANHEDONIA |
1 |
0.0000 |
| 377 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 378 |
FEAR |
1 |
0.0000 |
| 379 |
PAIN OF SKIN |
1 |
0.0000 |
| 380 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 381 |
RASH |
16 |
0.0000 |
| 382 |
SKIN LESION |
1 |
0.0000 |
| 383 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 384 |
CONDITION AGGRAVATED |
11 |
0.0000 |
| 385 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 386 |
WOUND |
1 |
0.0000 |
| 387 |
BLISTER |
2 |
0.0000 |
| 388 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 389 |
FATIGUE |
27 |
0.0000 |
| 390 |
DIZZINESS |
17 |
0.0000 |
| 391 |
ERYTHEMA |
7 |
0.0000 |
| 392 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 393 |
APHASIA |
1 |
0.0000 |
| 394 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 395 |
INJECTION SITE RASH |
1 |
0.0000 |
| 396 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 397 |
GYNAECOMASTIA |
1 |
0.0000 |
| 398 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 399 |
WEIGHT DECREASED |
9 |
0.0000 |
| 400 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 401 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 402 |
NIGHT SWEATS |
1 |
0.0000 |
| 403 |
AMNESIA |
2 |
0.0000 |
| 404 |
ALOPECIA |
6 |
0.0000 |
| 405 |
CHOLELITHIASIS |
1 |
0.0000 |
| 406 |
IMPAIRED HEALING |
1 |
0.0000 |
| 407 |
EYE DISORDER |
1 |
0.0000 |
| 408 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 409 |
VIRAL INFECTION |
1 |
0.0000 |
| 410 |
DEHYDRATION |
4 |
0.0000 |
| 411 |
SKIN DISORDER |
1 |
0.0000 |
| 412 |
URINARY RETENTION |
1 |
0.0000 |
| 413 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 414 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 415 |
VISION BLURRED |
4 |
0.0000 |
| 416 |
ILLNESS |
3 |
0.0000 |
| 417 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 418 |
RASH MACULAR |
1 |
0.0000 |
| 419 |
HEART RATE DECREASED |
1 |
0.0000 |
| 420 |
HYPOXIA |
1 |
0.0000 |
| 421 |
SLEEP DISORDER |
2 |
0.0000 |
| 422 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 423 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 424 |
DYSURIA |
1 |
0.0000 |
| 425 |
INJECTION SITE MASS |
1 |
0.0000 |
| 426 |
DYSGEUSIA |
2 |
0.0000 |
| 427 |
EYE SWELLING |
1 |
0.0000 |
| 428 |
HOT FLUSH |
2 |
0.0000 |
| 429 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 430 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 431 |
PYREXIA |
9 |
0.0000 |
| 432 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 433 |
DISORIENTATION |
1 |
0.0000 |
| 434 |
DRUG INTERACTION |
4 |
0.0000 |
| 435 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 436 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 437 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 438 |
MYALGIA |
4 |
0.0000 |
| 439 |
PRURITUS |
9 |
0.0000 |
| 440 |
BALANCE DISORDER |
2 |
0.0000 |
| 441 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 442 |
CONSTIPATION |
5 |
0.0000 |
| 443 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 444 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 445 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 446 |
DEVICE ISSUE |
2 |
0.0000 |
| 447 |
THROAT IRRITATION |
1 |
0.0000 |
| 448 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 449 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 450 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 451 |
TINNITUS |
1 |
0.0000 |
| 452 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 453 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 454 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 455 |
SWELLING |
2 |
0.0000 |
| 456 |
ARRHYTHMIA |
1 |
0.0000 |
| 457 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 458 |
DYSPHAGIA |
2 |
0.0000 |
| 459 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 460 |
INFECTION |
3 |
0.0000 |
| 461 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 462 |
DYSPEPSIA |
2 |
0.0000 |
| 463 |
FLUID RETENTION |
1 |
0.0000 |
| 464 |
INJECTION SITE PAIN |
6 |
0.0000 |
| 465 |
SINUSITIS |
2 |
0.0000 |
| 466 |
HYPERTENSION |
4 |
0.0000 |
| 467 |
RASH PRURITIC |
1 |
0.0000 |
| 468 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 469 |
ARTHROPATHY |
1 |
0.0000 |
| 470 |
MEDICATION ERROR |
1 |
0.0000 |
| 471 |
PAIN |
11 |
0.0000 |
| 472 |
WEIGHT INCREASED |
4 |
0.0000 |
| 473 |
EYE PAIN |
1 |
0.0000 |
| 474 |
ASTHMA |
2 |
0.0000 |
| 475 |
FLATULENCE |
1 |
0.0000 |
| 476 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 477 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 478 |
CHILLS |
2 |
0.0000 |
| 479 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 480 |
STOMATITIS |
1 |
0.0000 |
| 481 |
VERTIGO |
1 |
0.0000 |
| 482 |
DISCOMFORT |
1 |
0.0000 |
| 483 |
FEELING HOT |
1 |
0.0000 |
| 484 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 485 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 486 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 487 |
MALAISE |
7 |
0.0000 |
| 488 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 489 |
RHINORRHOEA |
1 |
0.0000 |
| 490 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 491 |
HYPOTENSION |
3 |
0.0000 |
| 492 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 493 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 494 |
DYSPNOEA |
8 |
0.0000 |
| 495 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 496 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 497 |
BRONCHITIS |
1 |
0.0000 |
| 498 |
OFF LABEL USE |
11 |
0.0000 |
| 499 |
DRY MOUTH |
1 |
0.0000 |
| 500 |
DRUG ABUSE |
1 |
0.0000 |
| 501 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 502 |
COVID-19 |
2 |
0.0000 |
| 503 |
DIARRHOEA |
7 |
0.0000 |
| 504 |
CHEST PAIN |
2 |
0.0000 |
| 505 |
COUGH |
3 |
0.0000 |
| 506 |
CARDIAC DISORDER |
1 |
0.0000 |
| 507 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 508 |
ASTHENIA |
4 |
0.0000 |
| 509 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 510 |
SYNCOPE |
1 |
0.0000 |
| 511 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 512 |
PNEUMONIA |
3 |
0.0000 |
| 513 |
FALL |
3 |
0.0000 |
| 514 |
INFLUENZA |
1 |
0.0000 |
| 515 |
SEPSIS |
1 |
0.0000 |
| 516 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 517 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 518 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 519 |
DRY SKIN |
1 |
0.0000 |
| 520 |
ARTHRALGIA |
3 |
0.0000 |
| 521 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 522 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 523 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 524 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 525 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 526 |
MUSCLE SPASMS |
1 |
0.0000 |
| 527 |
BACK PAIN |
1 |
0.0000 |
| 528 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |